From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.20
First Reported 1999
Last Reported 2010
Negated 0
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 1.46
Pain Relevance 0.10

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
cardiac valve 1
MPEG1 (Homo sapiens)
Pain Link Frequency Relevance Heat
anesthesia 1 95.20 Very High Very High Very High
carpal tunnel syndrome 6 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 20 100.00 Very High Very High Very High
Valvular Heart Disease Other Than Mitral Valve Prolapse 2 100.00 Very High Very High Very High
Mucopolysaccharidoses 2 99.82 Very High Very High Very High
Mucopolysaccharidosis I 28 98.40 Very High Very High Very High
Congenital Anomalies 9 96.72 Very High Very High Very High
Coronary Heart Disease 3 85.24 High High
Neurologic Manifestations 1 75.92 Quite High
Disease Progression 3 56.40 Quite High
Lysosome Storage Disease 7 50.00 Quite Low
Syndrome 8 39.84 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A recent case report of two siblings with Hurler-Scheie syndrome who began ERT at 5 months and 5 years of age, respectively, suggests that many MPS I disease manifestations, including cardiac valve disease, can be prevented if ERT is begun at an early age, but only partially reversed or stabilized if begun at a later age (Gabrielli et al. 2009).
Negative_regulation (prevented) of MPS I in cardiac valve associated with valvular heart disease other than mitral valve prolapse, mucopolysaccharidosis i and disease
1) Confidence 0.20 Published 2010 Journal J Inherit Metab Dis Section Body Doc Link PMC2903709 Disease Relevance 1.10 Pain Relevance 0
Mucopolysaccharidosis type I (MPS I), a deficiency in the lysosomal enzyme alpha-L-iduronidase (IDUA), is characterized by skeletal abnormalities, hepatosplenomegaly and neurological dysfunction.
Negative_regulation (deficiency) of MPS I associated with anesthesia, congenital anomalies and mucopolysaccharidoses
2) Confidence 0.02 Published 1999 Journal Hum. Gene Ther. Section Abstract Doc Link 10498248 Disease Relevance 0.36 Pain Relevance 0.10

General Comments

This test has worked.

Personal tools